Application Note – Bispecific antibodies: rising stars in antibody therapeutics
Bispecific antibodies (bsAbs) are antibodies containing two antigen-binding sites and therefore can simultaneously target two different epitopes. As the rising star in antibody therapeutics, bispecific antibodies have accounted for nearly 20% of the clinical antibody pipeline, with about 160 bsAbs currently in clinical trials.
Download this Application Note by Sino Biological to learn more about:
- Bispecific antibody drugs on the market
- Design and engineering of biospecifics antibodies
- Bispecific antibody expression and production
- Sino Biological’s fast and efficient bsAb expression services
And much more!
With the rapid development of recombinant DNA technology and a deep understanding of antibody engineering diverse bispecific antibody formats are emerging to pursue optimal biological activity and clinical purposes. Bispecific antibodies have already shown great therapeutics potential in cancer and other diseases, such as diabetes, Alzheimer’s disease and ophthalmological diseases.
Explore Sino Biological’s fast and efficient bispecific antibody expression services at: https://www.sinobiological.com/services/bispecific-antibody-service
This content was provided by Sino Biological.
